Leanna M Ross1, Cris A Slentz1, Alyssa M Zidek1, Kim M Huffman1, Irina Shalaurova2, James D Otvos2, Margery A Connelly2, Virginia B Kraus1, Connie W Bales3,4, Joseph A Houmard5, William E Kraus1. 1. Department of Medicine, Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, United States. 2. Laboratory Corporation of America Holdings (LabCorp), Morrisville, NC, United States. 3. Center for the Study of Aging, Department of Medicine, Duke University School of Medicine, Durham, NC, United States. 4. Geriatric Research, Education, and Clinical Center, Durham VA Medical Center, Durham, NC, United States. 5. Department of Kinesiology, East Carolina University, Greenville, NC, United States.
Abstract
BACKGROUND: Lipoprotein Insulin Resistance Index (LP-IR) and Diabetes Risk Index are novel spectroscopic multimarkers of insulin resistance and type 2 diabetes risk. As the Studies of a Targeted Risk Reduction Intervention through Defined Exercise (STRRIDE) randomized trials have previously demonstrated the ability of exercise training to improve traditional markers of insulin action, the aim of this study was to examine the effects of exercise amount, intensity, and mode on LP-IR and the Diabetes Risk Index. METHODS: A total of 503 adults with dyslipidemia [STRRIDE I (n = 194), STRRIDE AT/RT (n = 139)] or prediabetes [STRRIDE-PD (n = 170)] were randomized to control or one of 10 exercise interventions, ranging from doses of 8-23 kcal/kg/week; intensities of 50-75% V̇O2peak; and durations of 6-8 months. Two groups included resistance training and one included dietary intervention (7% weight loss goal). Fasting plasma samples were obtained at baseline and 16-24 h after the final exercise bout. LP-IR, the Diabetes Risk Index, and concentrations of the branched chain amino acids valine and leucine were determined using nuclear magnetic resonance spectroscopy. LP-IR and the Diabetes Risk Index scores range from 0-100 and 1-100, respectively (greater scores indicate greater risk). Paired t-tests determined significance within groups (p < 0.05). RESULTS: After training, six exercise groups significantly improved LP-IR (ranging from -4.4 ± 8.2 to -12.4 ± 14.1), and four exercise groups significantly improved the Diabetes Risk Index (ranging from -2.8 ± 8.2 to -8.3 ± 10.4). The most beneficial interventions for both LP-IR and the Diabetes Risk Index were low amount/moderate intensity aerobic, aerobic plus resistance, and aerobic plus diet. SUMMARY: Multiple exercise interventions improved LP-IR and the Diabetes Risk Index. In those with dyslipidemia, adding resistance to aerobic training elicited a synergistic effect on insulin resistance and type 2 diabetes risk. In individuals with prediabetes, combining a dietary intervention and weight loss with aerobic training resulted in the most robust type 2 diabetes risk improvement.
BACKGROUND: Lipoprotein Insulin Resistance Index (LP-IR) and Diabetes Risk Index are novel spectroscopic multimarkers of insulin resistance and type 2 diabetes risk. As the Studies of a Targeted Risk Reduction Intervention through Defined Exercise (STRRIDE) randomized trials have previously demonstrated the ability of exercise training to improve traditional markers of insulin action, the aim of this study was to examine the effects of exercise amount, intensity, and mode on LP-IR and the Diabetes Risk Index. METHODS: A total of 503 adults with dyslipidemia [STRRIDE I (n = 194), STRRIDE AT/RT (n = 139)] or prediabetes [STRRIDE-PD (n = 170)] were randomized to control or one of 10 exercise interventions, ranging from doses of 8-23 kcal/kg/week; intensities of 50-75% V̇O2peak; and durations of 6-8 months. Two groups included resistance training and one included dietary intervention (7% weight loss goal). Fasting plasma samples were obtained at baseline and 16-24 h after the final exercise bout. LP-IR, the Diabetes Risk Index, and concentrations of the branched chain amino acids valine and leucine were determined using nuclear magnetic resonance spectroscopy. LP-IR and the Diabetes Risk Index scores range from 0-100 and 1-100, respectively (greater scores indicate greater risk). Paired t-tests determined significance within groups (p < 0.05). RESULTS: After training, six exercise groups significantly improved LP-IR (ranging from -4.4 ± 8.2 to -12.4 ± 14.1), and four exercise groups significantly improved the Diabetes Risk Index (ranging from -2.8 ± 8.2 to -8.3 ± 10.4). The most beneficial interventions for both LP-IR and the Diabetes Risk Index were low amount/moderate intensity aerobic, aerobic plus resistance, and aerobic plus diet. SUMMARY: Multiple exercise interventions improved LP-IR and the Diabetes Risk Index. In those with dyslipidemia, adding resistance to aerobic training elicited a synergistic effect on insulin resistance and type 2 diabetes risk. In individuals with prediabetes, combining a dietary intervention and weight loss with aerobic training resulted in the most robust type 2 diabetes risk improvement.
Authors: Danilo Iannetta; Erin Calaine Inglis; Anmol T Mattu; Federico Y Fontana; Silvia Pogliaghi; Daniel A Keir; Juan M Murias Journal: Med Sci Sports Exerc Date: 2020-02 Impact factor: 5.411
Authors: William E Kraus; Joseph A Houmard; Brian D Duscha; Kenneth J Knetzger; Michelle B Wharton; Jennifer S McCartney; Connie W Bales; Sarah Henes; Gregory P Samsa; James D Otvos; Krishnaji R Kulkarni; Cris A Slentz Journal: N Engl J Med Date: 2002-11-07 Impact factor: 91.245
Authors: Cris A Slentz; Lori A Bateman; Leslie H Willis; A Tamlyn Shields; Charles J Tanner; Lucy W Piner; Victoria H Hawk; Michael J Muehlbauer; Greg P Samsa; Rendon C Nelson; Kim M Huffman; Connie W Bales; Joseph A Houmard; William E Kraus Journal: Am J Physiol Endocrinol Metab Date: 2011-08-16 Impact factor: 4.310
Authors: Sagar B Dugani; Akintunde O Akinkuolie; Nina Paynter; Robert J Glynn; Paul M Ridker; Samia Mora Journal: JAMA Cardiol Date: 2016-05-01 Impact factor: 14.676
Authors: Jose L Flores-Guerrero; Maryse C J Osté; Lyanne M Kieneker; Eke G Gruppen; Justyna Wolak-Dinsmore; James D Otvos; Margery A Connelly; Stephan J L Bakker; Robin P F Dullaart Journal: J Clin Med Date: 2018-12-04 Impact factor: 4.241